Making CAR-T “Druggable”
The terrible news this week that Tmunity Therapeutics, a clinical stage biotherapeutics company, has halted...
The terrible news this week that Tmunity Therapeutics, a clinical stage biotherapeutics company, has halted...
Australia’s medical community has welcomed a new ‘patent box’ tax regime designed to encourage further...
he federal government’s “patent box” initiative caught the eye of Australia’s biotech sector in Tuesday...
Prescient Therapeutics (ASX:PTX) has announced a new research program with the Peter MacCallum Cancer Centre...
Prescient Therapeutics Ltd (ASX:PTX) has signed an agreement related to advancing a new research program with...
Prescient Therapeutics (PTX) has announced a new research program with the Peter MacCallum Cancer Centre...
Biotech company Prescient Therapeutics (ASX:PTX) had an important announcement for the market this morning, after strengthening its...
Prescient Therapeutics has inked a new deal with leading research organisation Peter MacCallum Cancer Centre...
With the number of days left to file March quarterly reports running a little short...
Melbourne biotech company Prescient Therapeutics (ASX:PTX) says a clinical trial evaluating its PTX-200 drug candidate to treat...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.